Search Results

Your search matched 49 results

  • 1
  • 2
#1

What to Expect From Contact Tracing in Our Next Phase of COVID-19 | Blog

You might want to think twice about ignoring that call from a random number.

#2

As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#3

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#4

How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#5

Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives

Virtual delivery requires you to rethink your content and approaches.

#6

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#7

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#8

The Syneos Health Podcast, Coronavirus Special Edition: The Leader's Experience | Perspectives

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.

#9

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#10

Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives

To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.

#11

Meet Think Bank | Perspectives

Think Bank is an agile way to answer complex questions.

#12

Demonstrating Value in the Real World | Perspectives

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#13

COVID-19: How are Payers Managing These Days? | Perspectives

How are payers responding to COVID-19?

#14

Our Virtual Reality | Perspectives

Virtual collaboration isn’t the future of work – it's the wave of the present

#15

The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives

In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.

#16

2020 Employee Communications and Behavioral Science Contingency | Perspectives

Recommendations for activities to inform and engage

#17

MM&M eBook: Marketing in a Crisis | In The Media

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#18

Payer Priorities in a Pandemic | In The Media

What are payers focused on during the COVID-19 pandemic?

#19

P2P Networks Huge for COVID-19 Patients, Responders | Blog

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#20

COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#21

Here are a Few Changes We Can Expect to See in Our World After COVID | Blog

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#22

There’s a Looming Mental Health Crisis but Tech is Here to Help | Blog

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#23

Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives

COVID-19 has introduced an era of unprecedented events to industries across the globe.

#24

Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog

Patients are often at risk when presented with mixed messages.

#25

Is Your Mask Up to the Task? | Blog

Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”

#26

Big Pharma Fund Fights Menacing Superbugs | Blog

COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.

#27

Novo Nordisk Tailors Launch for COVID-era Customers | Blog

Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.

#28

COVID’s Consequences Clearer as Cancer Cases Climb | Blog

At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.

#29

Why Hospitals Really Like the Changes They Made for COVID-19 | Blog

As the pandemic surged, New York City’s Mt.

#30

Fors Marsh Group Selected by HHS to Build $250 Million Public Coronavirus Campaign | Blog

The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.

  • 1
  • 2